Insoma Bio, Inc.
Durham, NC
- UEI
- LF3PGT7RN6G7
- CAGE
- 87PK7
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 701 W Main St #410, Durham, NC 27701, USA
- Website
- insomabio.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Insoma Bio, Inc.
Insoma Bio, Inc. is a biotechnology company based in Durham, North Carolina, that specializes in developing innovative biomaterials for medical applications, with a focus on tissue engineering and regenerative medicine. Registered in SAM.gov since November 2018, the company has been actively pursuing federal grant awards to advance its proprietary Fractomer technology, a recombinant elastin-based biomaterial platform that can be used in various medical interventions. The company's primary technological innovation centers on creating injectable protein matrices that can support tissue regeneration, repair, and reconstruction across multiple medical domains.
Through federal grant awards from agencies like the National Science Foundation, National Institute of General Medical Sciences, National Institute of Neurological Disorders and Stroke, and National Institute of Diabetes and Digestive and Kidney Diseases, Insoma Bio, Inc. has pursued research and development in several critical medical areas. These include developing an off-the-shelf alternative to autologous fat grafting for soft tissue repair, enhancing peripheral nerve repair with an injectable polypeptide scaffold, creating a recombinant elastin skin substitute for burn wound treatment, and developing fully defined matrices for organoid culture. The grants, ranging from approximately $250,000 to nearly $1 million, have supported Phase I and Phase II Small Business Innovation Research (SBIR) projects aimed at advancing the company's biomaterial technology. Each project demonstrates Insoma Bio's commitment to creating scalable, biocompatible solutions that can improve surgical outcomes, reduce patient recovery times, and address significant medical challenges in tissue engineering and regenerative medicine.
Quick answers
What is Insoma Bio, Inc.'s UEI?
Insoma Bio, Inc.'s Unique Entity ID (UEI) in SAM.gov is LF3PGT7RN6G7.
What is Insoma Bio, Inc.'s CAGE code?
Insoma Bio, Inc.'s CAGE code is 87PK7.
Where is Insoma Bio, Inc. located?
Insoma Bio, Inc.'s physical address in SAM.gov is 701 W Main St #410, Durham, NC 27701, USA.
Is Insoma Bio, Inc. registered in SAM.gov?
Yes. Insoma Bio, Inc.'s SAM.gov registration is active through July 24, 2027.
What is Insoma Bio, Inc.'s most recent federal award?
Insoma Bio, Inc.'s most recent federal grant award is An off the shelf alternative to FAT transfer for soft tissue repair - project summary the goal of this phase i sbir… (R43GM153037), from National Institute of General Medical Sciences, on September 1, 2024.
On GovTribe
See Insoma Bio, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors